Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Antero Resources Corp a un objectif de cours consensuel de $41.25 basé sur les évaluations de 21 analystes. Le plus élevé est $58, publié par Raymond James le juillet 22, 2025. Le plus bas est $27, publié par Truist Securities le avril 5, 2024. Les 3 évaluations d’analystes les plus récentes ont été publiées par Wells Fargo, Barclays et Morgan Stanley le novembre 3, 2025, octobre 30, 2025 et octobre 14, 2025, respectivement. Avec un objectif de cours moyen de $41 entre Wells Fargo, Barclays et Morgan Stanley, il existe une variation implicite de 18.63% upside pour Antero Resources Corp selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 12.85% | Wells Fargo | $39 → $39 | Upgrade | Equal-Weight → Overweight | |||
10/30/2025 | 15.74% | Barclays | $42 → $40 | Maintains | Equal-Weight | |||
10/14/2025 | 27.31% | Morgan Stanley | $47 → $44 | Maintains | Overweight | |||
10/07/2025 | 21.53% | Barclays | $43 → $42 | Maintains | Equal-Weight | |||
10/03/2025 | 36% | Jefferies | $50 → $47 | Maintains | Buy | |||
10/02/2025 | 27.31% | JP Morgan | $49 → $44 | Maintains | Overweight | |||
09/23/2025 | 12.85% | Citigroup | $37 → $39 | Upgrade | Neutral → Buy | |||
09/15/2025 | 18.63% | Mizuho | $49 → $41 | Maintains | Outperform | |||
09/15/2025 | 21.53% | UBS | $43 → $42 | Maintains | Buy | |||
08/20/2025 | 24.42% | UBS | → $43 | Upgrade | Neutral → Buy | |||
08/18/2025 | -7.41% | Roth Capital | $44 → $32 | Downgrade | Buy → Neutral | |||
08/13/2025 | 59.14% | Scotiabank | $53 → $55 | Maintains | Sector Outperform | |||
08/04/2025 | 36% | Morgan Stanley | $46 → $47 | Maintains | Overweight | |||
07/22/2025 | 67.82% | Raymond James | $57 → $58 | Maintains | Strong Buy | |||
07/15/2025 | 12.85% | Wells Fargo | $41 → $39 | Maintains | Equal-Weight | |||
07/11/2025 | 53.36% | Scotiabank | $46 → $53 | Maintains | Sector Outperform | |||
07/08/2025 | 41.78% | JP Morgan | $44 → $49 | Maintains | Overweight | |||
07/07/2025 | 24.42% | Barclays | $38 → $43 | Maintains | Equal-Weight | |||
06/16/2025 | 15.74% | Wells Fargo | $42 → $40 | Maintains | Equal-Weight | |||
05/23/2025 | 36% | B of A Securities | $44 → $47 | Maintains | Buy | |||
05/13/2025 | 64.93% | Raymond James | $56 → $57 | Maintains | Strong Buy | |||
05/13/2025 | 41.78% | Mizuho | $47 → $49 | Upgrade | Neutral → Outperform | |||
05/07/2025 | 24.42% | UBS | $41 → $43 | Maintains | Neutral | |||
05/02/2025 | 27.31% | JP Morgan | $48 → $44 | Maintains | Overweight | |||
04/29/2025 | 27.31% | B of A Securities | $46 → $44 | Maintains | Buy | |||
04/08/2025 | 33.1% | TD Cowen | $40 → $46 | Upgrade | Hold → Buy | |||
04/02/2025 | 36% | Mizuho | $41 → $47 | Maintains | Neutral | |||
03/19/2025 | 21.53% | Wells Fargo | $40 → $42 | Maintains | Equal-Weight | |||
03/13/2025 | 36% | JP Morgan | $45 → $47 | Maintains | Overweight | |||
02/14/2025 | 9.95% | Barclays | $36 → $38 | Maintains | Equal-Weight | |||
02/13/2025 | 27.31% | UBS | $39 → $44 | Maintains | Neutral | |||
01/30/2025 | 4.17% | Barclays | $30 → $36 | Maintains | Equal-Weight | |||
01/23/2025 | 73.61% | Raymond James | $44 → $60 | Maintains | Strong Buy | |||
01/23/2025 | 27.31% | Goldman Sachs | $39 → $44 | Maintains | Buy | |||
01/17/2025 | 18.63% | Mizuho | $40 → $41 | Maintains | Neutral | |||
01/17/2025 | 12.85% | UBS | $35 → $39 | Maintains | Neutral | |||
01/17/2025 | — | Benchmark | — | Reiterates | Hold → Hold | |||
01/14/2025 | 9.95% | JP Morgan | $36 → $38 | Maintains | Overweight | |||
01/13/2025 | 33.1% | B of A Securities | $36 → $46 | Maintains | Buy | |||
01/13/2025 | 9.95% | Truist Securities | $28 → $38 | Maintains | Hold | |||
12/17/2024 | -7.41% | Wells Fargo | $24 → $32 | Upgrade | Underweight → Equal-Weight | |||
12/16/2024 | 15.74% | Mizuho | $35 → $40 | Maintains | Neutral | |||
12/09/2024 | 1.27% | UBS | $31 → $35 | Maintains | Neutral | |||
12/06/2024 | 1.27% | Citigroup | $29 → $35 | Maintains | Neutral | |||
11/21/2024 | 27.31% | Raymond James | $34 → $44 | Maintains | Strong Buy | |||
11/04/2024 | -10.3% | UBS | $33 → $31 | Maintains | Neutral | |||
10/28/2024 | 4.17% | B of A Securities | → $36 | Initiates | → Buy | |||
10/18/2024 | -30.56% | Wells Fargo | $25 → $24 | Maintains | Underweight | |||
10/16/2024 | -4.51% | UBS | → $33 | Initiates | → Neutral | |||
10/04/2024 | -1.62% | BMO Capital | $33 → $34 | Maintains | Market Perform | |||
10/03/2024 | -13.19% | Barclays | $32 → $30 | Maintains | Equal-Weight | |||
10/01/2024 | -27.66% | Wells Fargo | $34 → $25 | Downgrade | Overweight → Underweight | |||
09/30/2024 | -18.98% | Truist Securities | $29 → $28 | Maintains | Hold | |||
09/17/2024 | -16.09% | Citigroup | → $29 | Initiates | → Neutral | |||
09/16/2024 | 9.95% | Morgan Stanley | $39 → $38 | Maintains | Overweight | |||
09/16/2024 | 1.27% | Mizuho | $37 → $35 | Maintains | Neutral | |||
09/12/2024 | -13.19% | JP Morgan | $37 → $30 | Maintains | Overweight | |||
09/11/2024 | 7.06% | Wolfe Research | → $37 | Upgrade | Peer Perform → Outperform | |||
09/06/2024 | -7.41% | Goldman Sachs | $36 → $32 | Maintains | Buy | |||
08/27/2024 | -7.41% | Roth MKM | → $32 | Initiates | → Buy | |||
08/20/2024 | 27.31% | Scotiabank | $40 → $44 | Upgrade | Sector Perform → Sector Outperform | |||
08/14/2024 | -1.62% | Wells Fargo | $38 → $34 | Maintains | Overweight | |||
07/18/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
07/17/2024 | 9.95% | Wells Fargo | $43 → $38 | Maintains | Overweight | |||
07/11/2024 | 18.63% | Jefferies | $40 → $41 | Maintains | Buy | |||
05/28/2024 | 4.17% | Goldman Sachs | $32 → $36 | Maintains | Buy | |||
05/13/2024 | 7.06% | Mizuho | $29 → $37 | Maintains | Neutral | |||
04/30/2024 | 15.74% | Scotiabank | $36 → $40 | Maintains | Sector Perform | |||
04/30/2024 | 24.42% | Wells Fargo | $35 → $43 | Maintains | Overweight | |||
04/17/2024 | 4.17% | Morgan Stanley | $26 → $36 | Upgrade | Equal-Weight → Overweight | |||
04/15/2024 | -21.88% | Morgan Stanley | $26 → $27 | Maintains | Equal-Weight | |||
04/11/2024 | 4.17% | Scotiabank | $26 → $36 | Maintains | Sector Perform | |||
04/10/2024 | -7.41% | Barclays | → $32 | Initiates | → Equal-Weight | |||
04/05/2024 | -21.88% | Truist Securities | $28 → $27 | Maintains | Hold | |||
04/03/2024 | -16.09% | Mizuho | $28 → $29 | Maintains | Neutral | |||
03/28/2024 | -24.77% | Morgan Stanley | $24 → $26 | Maintains | Equal-Weight | |||
03/27/2024 | -7.41% | JP Morgan | $30 → $32 | Maintains | Overweight | |||
03/20/2024 | -13.19% | JP Morgan | $27 → $30 | Upgrade | Neutral → Overweight | |||
03/15/2024 | -18.98% | Mizuho | $27 → $28 | Maintains | Neutral | |||
02/21/2024 | -16.09% | Wells Fargo | $26 → $29 | Maintains | Overweight | |||
02/16/2024 | -18.98% | Truist Securities | $27 → $28 | Maintains | Hold | |||
01/24/2024 | -7.41% | Raymond James | $28 → $32 | Maintains | Strong Buy | |||
01/11/2024 | -24.77% | Benchmark | $32 → $26 | Maintains | Buy | |||
01/03/2024 | -21.88% | Mizuho | → $27 | Downgrade | Buy → Neutral | |||
01/02/2024 | -18.98% | Raymond James | $37 → $28 | Maintains | Strong Buy | |||
12/14/2023 | -24.77% | Wells Fargo | $32 → $26 | Upgrade | Equal-Weight → Overweight | |||
12/04/2023 | -18.98% | Truist Securities | $37 → $28 | Downgrade | Buy → Hold | |||
10/26/2023 | -7.41% | Benchmark | $36 → $32 | Maintains | Buy | |||
10/24/2023 | 7.06% | Raymond James | → $37 | Upgrade | Market Perform → Strong Buy | |||
10/20/2023 | -10.3% | Wells Fargo | $29 → $31 | Maintains | Equal-Weight | |||
10/03/2023 | -7.41% | Benchmark | $36 → $32 | Maintains | Buy | |||
10/02/2023 | -27.66% | Morgan Stanley | $23 → $25 | Maintains | Equal-Weight | |||
09/18/2023 | 9.95% | Mizuho | $39 → $38 | Maintains | Buy | |||
09/11/2023 | 4.17% | Truist Securities | $32 → $36 | Maintains | Buy | |||
09/01/2023 | -16.09% | Wells Fargo | $27 → $29 | Maintains | Equal-Weight | |||
08/23/2023 | -7.41% | Goldman Sachs | $28 → $32 | Maintains | Buy | |||
08/16/2023 | 12.85% | Mizuho | $40 → $39 | Maintains | Buy | |||
07/28/2023 | -21.88% | Wells Fargo | $26 → $27 | Maintains | Equal-Weight | |||
07/27/2023 | -7.41% | Benchmark | $36 → $32 | Maintains | Buy | |||
07/18/2023 | -33.45% | Morgan Stanley | $24 → $23 | Maintains | Equal-Weight |
Le dernier objectif de prix pour Antero Resources (NYSE:AR) a été rapporté par Wells Fargo le novembre 3, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $39.00 s'attendant à ce que AR se rise dans les 12 prochains mois (un possible changement de 12.85% upside). 44 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Antero Resources (NYSE:AR) a été fournie par Wells Fargo, et Antero Resources amélioré leur note overweight.
La dernière amélioration pour Antero Resources Corp a eu lieu le novembre 3, 2025 lorsque Wells Fargo a augmenté leur objectif de prix à $39. Wells Fargo avait précédemment an equal-weight pour Antero Resources Corp.
La dernière réduction pour Antero Resources Corp a eu lieu le août 18, 2025 lorsque Roth Capital a changé leur objectif de prix de $44 à $32 pour Antero Resources Corp.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Antero Resources, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Antero Resources a été déposée le novembre 3, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 3, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Antero Resources (AR) était un amélioré avec un objectif de prix de $39.00 à $39.00. Le prix actuel de Antero Resources (AR) est de $34.56, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.